SCHEMBL8872006

SCHEMBL8872006

CN1CCC(CCN2CCCC2c2ccc(OC(=O)Nc3ccccc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
ACHE P22303 3/20 0.44
OPRM1 P35372 2/20 0.44
OPRD1 P41143 2/20 0.44
OPRK1 P41145 2/20 0.44
BCHE P06276 3/20 0.44
MAOB P27338 1/20 0.44
DRD2 P14416 1/20 0.41
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8871221 0.76 MEN1 (0.47) ALDH1A1MEN1HPGDKMT2AKDM4E
SCHEMBL8873578 0.73 BCHE (0.47) ALDH1A1ACHEOPRM1OPRD1OPRK1
SCHEMBL8871835 0.73 ALDH1A1 (0.51) NPSR1ALDH1A1HTTMEN1KMT2A
SCHEMBL5175960 0.71 FAAH (0.55) RAB9ABCHEMAOBKDM4E
SCHEMBL8539481 0.70 ACHE (0.42) ALDH1A1ACHEOPRM1OPRD1OPRK1
SCHEMBL8871798 0.70 KDM4E (0.45) GAARAB9AALDH1A1SMN1; SMN2MEN1
SCHEMBL8544287 0.69 HRH3 (0.45) ALDH1A1ACHEOPRM1OPRK1HPGD
SCHEMBL8544368 0.68 ACHE (0.40) ALDH1A1ACHEOPRM1OPRD1OPRK1
SCHEMBL31029109 0.68 OPRK1 (0.56) GAANPSR1ALDH1A1SMN1; SMN2HTT
SCHEMBL6627559 0.68 GAA (0.62) GAANPSR1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5591856-A CHEMICAL INTERMEDIATES, TREATMENT OF ALZHEIMER'S DISEASE HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1997-01-07 US disclosed
US-5554750-A TO RELIEVE MEMORY DYSFUNCTIONS; TREATMENT OF ALZHEMER*S HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1996-09-10 US disclosed
EP-0671388-A1 (Pyrrolidinyl)phenyl carbamates and intermediate compounds, processes for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-09-13 EP disclosed
US-5405845-A Administering to relieve memory dysfunction; treatment of Alzheimer's disease HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1995-04-11 US disclosed
US-5338739-A Memory dysfunction relieving compounds HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-16 US disclosed